{"id":51957,"date":"2025-05-02T11:24:39","date_gmt":"2025-05-02T09:24:39","guid":{"rendered":"https:\/\/dzl.de\/?p=51957"},"modified":"2025-05-09T11:32:08","modified_gmt":"2025-05-09T09:32:08","slug":"a-tandem-approach-to-a-breakthrough-therapy-innovative-stem-cell-strategy-for-primary-ciliary-dyskinesia-pcd","status":"publish","type":"post","link":"https:\/\/dzl.de\/en\/news\/a-tandem-approach-to-a-breakthrough-therapy-innovative-stem-cell-strategy-for-primary-ciliary-dyskinesia-pcd\/","title":{"rendered":"A Tandem Approach to a Breakthrough Therapy: Innovative Stem Cell Strategy for Primary Ciliary Dyskinesia (PCD)"},"content":{"rendered":"<div class=\"teaser-text text-lg-left breath-text-blau\">\n<p>DZL early-career researchers from the BREATH site ,Dr. Laura von Schledorn (LEBAO, MHH) and Dr. Ben Ole Staar (Department of Pulmonology and Infectiology, MHH) have been selected for the National Translational Tandem Program for Gene- and Cell-Based Therapies (nTTP-GCT). Their interdisciplinary team, combining basic research and clinical expertise, aims to develop a novel stem cell therapy that could sustainably repair the damaged airway epithelium in PCD patients.<\/p>\n<\/div>\n<div class=\"news-text-wrap text-lg-left section-bottom-34\">\n<p><strong>A New Therapeutic Approach for an Incurable Disease<\/strong><br \/>\nPCD (Primary Ciliary Dyskinesia) is a rare disease that disrupts the function of cilia in the airways. As a result, the mucociliary clearance system fails, preventing the effective removal of mucus and pathogens. This leads to chronic respiratory infections and progressive lung damage. Currently, there are only symptomatic treatments, and no approved causal therapy exists.<br \/>\nIn their project, \"Exploring the Therapeutic Potential of hiPSC-Derived Basal Cells in the Context of Primary Ciliary Dyskinesia (PCD) Utilizing an In Vitro Cell Therapy Model,\" which is funded with nearly \u20ac150,000, the research tandem explores an innovative solution:\u00a0The transplantation of hiPSC-derived basal cells (iBCs)\u2014stem cells derived from a patient\u2019s own cells, genetically corrected, and differentiated into basal cells. These cells are expected to integrate into the damaged airway epithelium and form functional cilia.\u00a0\u201cOur research could mark a turning point in PCD treatment,\u201d explains Dr. Laura von Schledorn. \u201cIf we succeed in regenerating the diseased epithelium with genetically corrected stem cells, we could develop a causal therapy for PCD in the long term.\u201d<\/p>\n<p><strong>Targeted Cell Therapy Using Innovative Methods<\/strong><br \/>\nTo facilitate the integration of stem cells into the airway epithelium, the team is investigating various Airway Surface Preparation Techniques (ASPT)\u2014targeted methods to prepare the airways for cell transplantation. These include chemical and physical procedures that selectively remove diseased tissue to create space for transplanted cells.<br \/>\n\u201cEven a small proportion of healthy, cilia-bearing cells could be enough to restore the lung\u2019s self-cleaning function,\u201d says Dr. Ben Ole Staar. \u201cWe are examining the minimum number of functional cells needed to achieve a significant improvement in mucociliary clearance.\u201d<\/p>\n<p><strong>From Laboratory Research to Clinical Application<\/strong><br \/>\nInitially planned for 24 months, the project will evaluate the therapeutic potential of stem cell therapy in an in vitro model. In the long term, this approach could be further developed in clinical trials and potentially applied to other lung diseases such as cystic fibrosis (CF) or COPD.<br \/>\nFunding for the project is provided by the nTTP-GCT program, which supports innovative research approaches in gene and cell therapy. The tandem\u2019s work could be a key milestone on the path to a sustainable therapy for PCD patients.<\/p>\n<p>We wish Dr. von Schledorn and Dr. Staar great success with this promising project and in their future research endeavors!<br \/>\n<a href=\"https:\/\/www.breath-hannover.de\/en\/news-media\/news\/news-details.html?tx_news_pi1%5Bnews%5D=880&amp;cHash=e2813e713557da1e2a41d1c6f1944b1d\" target=\"_blank\" rel=\"noopener\">To the original news from BREATH<\/a><\/p>\n<p>Photo: private<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Two DZL early-career researchers from the BREATH site have been selected for the National Translational Tandem Program for Gene- and Cell-Based Therapies (nTTP-GCT). Their interdisciplinary team, combining basic research and clinical expertise, aims to develop a novel stem cell therapy that could sustainably repair the damaged airway epithelium in PCD patients.<\/p>\n","protected":false},"author":26,"featured_media":51955,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"none","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","footnotes":""},"categories":[28],"tags":[252,262],"class_list":["post-51957","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-end-stage-lung-disease","tag-pneumonia-and-acute-lung-injury"],"acf":[],"_links":{"self":[{"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/posts\/51957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/comments?post=51957"}],"version-history":[{"count":1,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/posts\/51957\/revisions"}],"predecessor-version":[{"id":51961,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/posts\/51957\/revisions\/51961"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/media\/51955"}],"wp:attachment":[{"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/media?parent=51957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/categories?post=51957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dzl.de\/en\/wp-json\/wp\/v2\/tags?post=51957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}